A randomized phase 2 study comparing EC or CMF versus nab-paclitaxel plus capecitabine as adjuvant chemotherapy for nonfrail elderly patients with moderate to high-risk early breast cancer (ICE II-GBG 52)
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
2015
|
| In: |
Cancer
Year: 2015, Volume: 121, Issue: 20, Pages: 3639-3648 |
| ISSN: | 0008-543X |
| Online Access: |
|
| Author Notes: | Gunter von Minckwitz, MD; Bettina Conrad, MD; Toralf Reimer, MD; Thomas Decker, MD; Holger Eidtmann, MD; Wolfgang Eiermann, MD; John Hackmann, MD; Volker Möbus, MD; Frederik Marmé, MD; Jochem Potenberg, MD; Elmar Stickeler, MD; Eike Simon, MD; Christoph Thomssen, MD; Jens Huober, MD; Carsten Denkert, MD;Joachim Alfer, MD; Christian Jackisch, MD; Valentina Nekljudova, PhD; Nicole Burchardi, PhD; and Sibylle Loibl, MD; for the German Breast Group Investigators |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 837671531 | ||
| 003 | DE-627 | ||
| 005 | 20240719201030.0 | ||
| 007 | tu | ||
| 008 | 151022s2015 xx ||||| 00| ||eng c | ||
| 035 | |a (DE-627)837671531 | ||
| 035 | |a (DE-576)983767153X | ||
| 035 | |a (DE-599)GBV837671531 | ||
| 035 | |a (OCoLC)1340145223 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Minckwitz, Gunter von |d 1964- |e VerfasserIn |0 (DE-588)172260035 |0 (DE-627)673296962 |0 (DE-576)133128202 |4 aut | |
| 245 | 1 | 2 | |a A randomized phase 2 study comparing EC or CMF versus nab-paclitaxel plus capecitabine as adjuvant chemotherapy for nonfrail elderly patients with moderate to high-risk early breast cancer (ICE II-GBG 52) |c Gunter von Minckwitz, MD; Bettina Conrad, MD; Toralf Reimer, MD; Thomas Decker, MD; Holger Eidtmann, MD; Wolfgang Eiermann, MD; John Hackmann, MD; Volker Möbus, MD; Frederik Marmé, MD; Jochem Potenberg, MD; Elmar Stickeler, MD; Eike Simon, MD; Christoph Thomssen, MD; Jens Huober, MD; Carsten Denkert, MD;Joachim Alfer, MD; Christian Jackisch, MD; Valentina Nekljudova, PhD; Nicole Burchardi, PhD; and Sibylle Loibl, MD; for the German Breast Group Investigators |
| 264 | 1 | |c 2015 | |
| 300 | |b graph. Darst. | ||
| 300 | |a 10 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 700 | 1 | |a Conrad, Bettina |e VerfasserIn |4 aut | |
| 700 | 1 | |a Reimer, Toralf |e VerfasserIn |4 aut | |
| 700 | 1 | |a Decker, Thomas |e VerfasserIn |4 aut | |
| 700 | 1 | |a Eidtmann, Holger |e VerfasserIn |4 aut | |
| 700 | 1 | |a Eiermann, Wolfgang |e VerfasserIn |4 aut | |
| 700 | 1 | |a Hackmann, John |e VerfasserIn |4 aut | |
| 700 | 1 | |a Möbus, Volker |e VerfasserIn |4 aut | |
| 700 | 1 | |a Marmé, Frederik |d 1974- |e VerfasserIn |0 (DE-588)132561972 |0 (DE-627)52394893X |0 (DE-576)299226549 |4 aut | |
| 700 | 1 | |a Potenberg, Jochem |e VerfasserIn |4 aut | |
| 700 | 1 | |a Stickeler, Elmar |e VerfasserIn |4 aut | |
| 700 | 1 | |a Simon, Eike |e VerfasserIn |4 aut | |
| 700 | 1 | |a Thomssen, Christoph |e VerfasserIn |4 aut | |
| 700 | 1 | |a Huober, Jens |e VerfasserIn |4 aut | |
| 700 | 1 | |a Denkert, Carsten |e VerfasserIn |4 aut | |
| 700 | 1 | |a Alfer, Joachim |e VerfasserIn |4 aut | |
| 700 | 1 | |a Jackisch, Christian |e VerfasserIn |4 aut | |
| 700 | 1 | |a Nekljudova, Valentina |e VerfasserIn |4 aut | |
| 700 | 1 | |a Burchardi, Nicole |e VerfasserIn |4 aut | |
| 700 | 1 | |a Loibl, Sibylle |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i In |t Cancer |d Hoboken, NJ : Wiley, 1948 |g 121(2015), 20, Seite 3639-3648 |w (DE-627)129067733 |w (DE-600)1429-1 |w (DE-576)014399172 |x 0008-543X |7 nnas |a A randomized phase 2 study comparing EC or CMF versus nab-paclitaxel plus capecitabine as adjuvant chemotherapy for nonfrail elderly patients with moderate to high-risk early breast cancer (ICE II-GBG 52) |
| 773 | 1 | 8 | |g volume:121 |g year:2015 |g number:20 |g pages:3639-3648 |g extent:10 |a A randomized phase 2 study comparing EC or CMF versus nab-paclitaxel plus capecitabine as adjuvant chemotherapy for nonfrail elderly patients with moderate to high-risk early breast cancer (ICE II-GBG 52) |
| 776 | 0 | 8 | |i Erscheint auch als |n Online-Ausgabe |a Minckwitz, Gunter von, 1964 - |t A randomized phase 2 study comparing EC or CMF versus nab-paclitaxel plus capecitabine as adjuvant chemotherapy for nonfrail elderly patients with moderate to high-risk early breast cancer (ICE II-GBG 52) |d 2015 |w (DE-627)1702141098 |
| 951 | |a AR | ||
| 992 | |a 20200716 | ||
| 993 | |a Article | ||
| 998 | |g 132561972 |a Marmé, Frederik |m 132561972:Marmé, Frederik |d 910000 |d 910400 |e 910000PM132561972 |e 910400PM132561972 |k 0/910000/ |k 1/910000/910400/ |p 9 | ||
| 999 | |a KXP-PPN837671531 |e 372529951X | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"language":["eng"],"physDesc":[{"noteIll":"graph. Darst.","extent":"10 S."}],"origin":[{"dateIssuedKey":"2015","dateIssuedDisp":"2015"}],"relHost":[{"recId":"129067733","id":{"eki":["129067733"],"issn":["0008-543X","1934-662X"],"zdb":["1429-1"]},"language":["eng"],"corporate":[{"role":"isb","display":"American Cancer Society"},{"role":"isb","display":"Society of Surgical Oncology"},{"role":"isb","display":"American Society for Therapeutic Radiology and Oncology"},{"role":"isb","display":"James Ewing Society"}],"part":{"extent":"10","pages":"3639-3648","volume":"121","text":"121(2015), 20, Seite 3639-3648","issue":"20","year":"2015"},"disp":"A randomized phase 2 study comparing EC or CMF versus nab-paclitaxel plus capecitabine as adjuvant chemotherapy for nonfrail elderly patients with moderate to high-risk early breast cancer (ICE II-GBG 52)Cancer","titleAlt":[{"title":"Cancer cytopathology"},{"title":"Cytopathology"},{"title":"Proceedings of the James Ewing Society"},{"title":"official journal of the James Ewing Society, the American Society of Clinical Oncology"},{"title":"official journal for the Society of Surgical Oncology (founded as James Ewing Society), the American Society of Clinical Oncology, American Association of Therapeutic Radiologists"}],"origin":[{"dateIssuedKey":"1948","dateIssuedDisp":"1948-","publisherPlace":"Hoboken, NJ ; Philadelphia, Pa. ; Hagerstown, Md. ; New York, NY","publisher":"Wiley ; Lippincott ; Lippincott-Raven Publishers ; Wiley"}],"type":{"bibl":"periodical"},"pubHistory":["1.1948 -"],"title":[{"title":"Cancer","title_sort":"Cancer","subtitle":"a journal of the American Cancer Society ; official journal for the Society of Surgical Oncology (founded as the James Ewing Soc., Inc.), the American Society for Therapeutics Radiology and Oncology"}],"note":["81.1997 - 114.2008 darin in jedem dritten Bd. als Section: Cancer cytopathology; ungezählte Beil.: Suppl"]}],"name":{"displayForm":["Gunter von Minckwitz, MD; Bettina Conrad, MD; Toralf Reimer, MD; Thomas Decker, MD; Holger Eidtmann, MD; Wolfgang Eiermann, MD; John Hackmann, MD; Volker Möbus, MD; Frederik Marmé, MD; Jochem Potenberg, MD; Elmar Stickeler, MD; Eike Simon, MD; Christoph Thomssen, MD; Jens Huober, MD; Carsten Denkert, MD;Joachim Alfer, MD; Christian Jackisch, MD; Valentina Nekljudova, PhD; Nicole Burchardi, PhD; and Sibylle Loibl, MD; for the German Breast Group Investigators"]},"type":{"bibl":"article-journal"},"recId":"837671531","person":[{"given":"Gunter von","family":"Minckwitz","display":"Minckwitz, Gunter von","role":"aut"},{"role":"aut","display":"Conrad, Bettina","family":"Conrad","given":"Bettina"},{"role":"aut","display":"Reimer, Toralf","given":"Toralf","family":"Reimer"},{"role":"aut","family":"Decker","given":"Thomas","display":"Decker, Thomas"},{"role":"aut","display":"Eidtmann, Holger","family":"Eidtmann","given":"Holger"},{"role":"aut","given":"Wolfgang","family":"Eiermann","display":"Eiermann, Wolfgang"},{"role":"aut","family":"Hackmann","given":"John","display":"Hackmann, John"},{"family":"Möbus","given":"Volker","display":"Möbus, Volker","role":"aut"},{"given":"Frederik","family":"Marmé","display":"Marmé, Frederik","role":"aut"},{"display":"Potenberg, Jochem","family":"Potenberg","given":"Jochem","role":"aut"},{"role":"aut","display":"Stickeler, Elmar","family":"Stickeler","given":"Elmar"},{"role":"aut","display":"Simon, Eike","family":"Simon","given":"Eike"},{"display":"Thomssen, Christoph","given":"Christoph","family":"Thomssen","role":"aut"},{"role":"aut","display":"Huober, Jens","given":"Jens","family":"Huober"},{"family":"Denkert","given":"Carsten","display":"Denkert, Carsten","role":"aut"},{"display":"Alfer, Joachim","given":"Joachim","family":"Alfer","role":"aut"},{"role":"aut","family":"Jackisch","given":"Christian","display":"Jackisch, Christian"},{"role":"aut","display":"Nekljudova, Valentina","given":"Valentina","family":"Nekljudova"},{"role":"aut","given":"Nicole","family":"Burchardi","display":"Burchardi, Nicole"},{"role":"aut","display":"Loibl, Sibylle","given":"Sibylle","family":"Loibl"}],"id":{"eki":["837671531"]},"title":[{"title_sort":"randomized phase 2 study comparing EC or CMF versus nab-paclitaxel plus capecitabine as adjuvant chemotherapy for nonfrail elderly patients with moderate to high-risk early breast cancer (ICE II-GBG 52)","title":"A randomized phase 2 study comparing EC or CMF versus nab-paclitaxel plus capecitabine as adjuvant chemotherapy for nonfrail elderly patients with moderate to high-risk early breast cancer (ICE II-GBG 52)"}]} | ||
| SRT | |a MINCKWITZGRANDOMIZED2015 | ||